← Open Payments lookup

DAVID DESAI: Open Payments

NPI 1740451566 · REDLANDS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$6,479 in 322 payments from 21 companies in 2025. Trend: 2023 $4,626 · 2024 $4,133 · 2025 $6,479

Food & beverage: $6,473Education: $5
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.41$1,053
Otsuka America Pharmaceutical, Inc.47$1,020
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)35$645
Janssen Pharmaceuticals, Inc31$636
Teva Pharmaceuticals USA, Inc.26$533
ABBVIE INC.33$525
Axsome Therapeutics, Inc.18$406
Lundbeck LLC16$369
Alkermes, Inc.12$270
Vanda Pharmaceuticals Inc.16$257

Products named: REXULTI, INGREZZA, CAPLYTA, VRAYLAR, Auvelity, AUSTEDO XR, SPRAVATO, INVEGA SUSTENNA.

Industry payments across CA — which companies pay providers there.